Newsroom

Filters: press-releases
x

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines for Europe applauds compromise on SPC manufacturing waiver

14 February 2019

Today, the European Council, Parliament and Commission agreed a compromise […]

Read more

New safeguards for patient safety as Falsified Medicines Directive comes into force

8 February 2019

The EU Falsified Medicines Directive was adopted in 2011 to […]

Read more

SUPPORT a comprehensive SPC manufacturing waiver: for patient access, sustainable healthcare and manufacturing jobs

7 February 2019

Open

SPC manufacturing waiver cannot be derailed by foreign vested interests

7 February 2019

Medicines for Europe calls on the European Council, Parliament and […]

Read more

A shared vision for better regulatory science: – Moving toward the light at the end of the tunnel

31 January 2019

This week in London, Medicines for Europe gathers regulators and […]

Read more

Efficient use of pharmacovigilance data essential for patient safety

30 January 2019

National authorities, regulators, industry leaders, and stakeholders gathered in London […]

Read more

Competition policy essential for access to medicines

28 January 2019

Medicines for Europe welcomes the publication of the European Commission […]

Read more

Crucial European Parliament vote vastly improves SPC manufacturing waiver

23 January 2019

Medicines for Europe welcomes today’s vote of the Legal Committee […]

Read more

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

The Medicines for Europe Board unanimously applauds last night’s vote […]

Read more

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Yesterday, 29th November, members of the Competitiveness Council expressed strong […]

Read more

Subscribe to our newsletter